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Abstract
Transforming growth factor beta (TGF-b) plays a pivotal role in Chagas disease, not only in the development of chagasic
cardiomyopathy, but also in many stages of the T. cruzi life cycle and survival in the host cell environment. The intracellular
signalingpathwaysutilizedbyT. cruzitoregulatethesemechanismsremainunknown.Toidentifyparasiteproteinsinvolvedin
the TGF-b response, we utilized a combined approach of two-dimensional gel electrophoresis (2DE) analysis and mass
spectrometry (MS) protein identification. Signaling via TGF-b is dependent on events of phosphorylation, which is one of the
most relevant and ubiquitous post-translational modifications for the regulation of gene expression, and especially in
trypanosomatids, since they lack several transcriptional control mechanisms. Here we show a kinetic view of T. cruzi
epimastigotes (Y strain) incubated with TGF-b for 1, 5, 30 and 60 minutes, which promoted a remodeling of the parasite
phosphorylation network andprotein expression pattern. Thealtered molecules areinvolved inavariety of cellularprocesses,
such as proteolysis, metabolism, heat shock response, cytoskeleton arrangement, oxidative stress regulation, translation and
signaltransduction.Atotalof75proteinspotswereup-ordown-regulatedmorethantwofoldafterTGF-btreatment,andfrom
these, 42 were identified by mass spectrometry, including cruzipain–the major T. cruzi papain-like cysteine proteinase that
playsan importantroleininvasion andparticipatesintheescapemechanisms usedbytheparasite toevadethe hostimmune
system. In our study, we observed that TGF-b addition favored epimastigote proliferation, corroborating 2DE data in which
proteins previously described to be involved in this process were positively stimulated by TGF-b.
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Introduction
Trypanosoma cruzi (T. cruzi) is a flagellate parasite that causes
Chagas disease - a widely distributed, debilitating illness that
constitutes a serious health problem in Latin America, affecting
10–12 million people and killing over 15,000 each year [1]. In this
disease, transforming growth factor beta (TGF-b) seems to play a
pivotal role in parasite infection, multiplication and the degree and
rate of cardiac fibrosis. TGF-b is involved in acute and chronic
chagasic cardiopathy. High levels of TGF-b and the activation of
its signaling pathway were shown to be peculiar aspects in patients
with chronic Chagas disease [2,3]. We recently demonstrated a
beneficial action of a TGF-b signalling inhibitor (SB-431542)
administered during the acute phase of experimental Chagas
disease, indicating that inhibition of TGF-b-induced activity could
represent a new therapeutic action for acute and chronic Chagas
disease treatment [4].
Besides its relevant role in the pathology of Chagas disease,
TGF-b was also observed to be intimately associated as a regulator
of different stages of the T. cruzi life cycle: 1) TGF-b can promote
parasite survival [4]; 2) host cell infection by T. cruzi is dependent
on active TGF-b and requires fully functional TGF-b receptors
[5–8]; 3) T. cruzi infection is able to induce the expression of TGF-
b in different models [2,9–11]; 4) the parasites are able to directly
activate latent TGF-b [7] and 5) amastigote forms of T. cruzi, once
in the cytoplasm, internalize host cell TGF-b, thereby regulating
their own intracellular life cycle [12]. Taken together, these data
indicate an important role for TGF-b in T. cruzi biology. However,
the mechanisms used by the parasite to recognize and respond to
this host-derived factor remain partially unknown.
TGF-b belongs to a group of structurally related polypeptides
collectively called ‘‘TGF-b superfamily’’. Members of this family
are involved in the regulation of a large variety of processes, such
as cell growth, tissue remodeling, development, differentiation,
motility, angiogenesis, inflammation, immune regulation, fibrosis,
apoptosis and tumorigenesis [13–16]. In its classic pathway,
TGF-b signaling begins by ligand binding to a transmembrane
receptor with intracellular serine/threonine kinase activity,
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phosphorylates and stimulates the serine/threonine kinase
activity of TGF-b receptor-I (TRI). Once activated, TRI
phosphorylates the cytoplasmic signaling proteins Smad-2 and
Smad-3, which then associate with Smad-4, translocate into the
nucleus as a multiprotein complex, and stimulate the transcrip-
tion of TGF-b responsive genes [17]. Several non-Smad signaling
pathways are also known to be activated or modulated by TGF-b
in eukaryotic cells. These include Jun-kinase, p38 MAP kinase,
Ras/MEK/ERK, Rho-A/p160ROCK, and PP2A/S6 kinase,
which are known as alternative pathways induced by TGF-b
[18]. Interestingly, homologs of Ras [19] Rho [20] and ERK
[21,22] have been characterized in T. cruzi and T. brucei,
suggesting that at least some of these alternative TGF-b pathways
might be functional in these parasites. Overall, signaling via
TGF-b seems always to be dependent on phosphorylation, which
is one of the most relevant and ubiquitous post-translational
modifications (PTM). This PTM is related to many molecular
mechanisms, such as protein activation, localization, interaction
and turnover. Phosphorylation is regulated by a highly dynamic
network of protein kinases and phosphatases that modulate
crucial cellular functions, including cell growth, proliferation,
differentiation, migration, metabolism and apoptosis [23,24].
The identification of differential patterns of protein phosphor-
ylation is possible through the use of a phosphoproteomic
approach, which provides insights into signal transduction
pathways, triggered by growth factors, including TGF-b [25,26].
Proteomic technology has already been used to study the three
most clinically relevant trypanosomatids T. cruzi, Leishmania and
T. brucei [23,27–34], performing as a powerful tool for the study of
global gene expression patterns, since it enables the analysis of the
whole protein profile of an organism in a single experiment. It is
worth reminding that trypanosomatids indiscriminately transcribe
most genes in large polycistronic units [35,36], unlike metazoa and
yeast, which use regulated transcription factors to direct the
expression of certain genes, thus emphasizing the critical role of
PTM in the regulation of T. cruzi proteins.
Due to the relevant role of TGF-b in T. cruzi biology, a study of
the proteins involved in TGF-b response is of crucial interest to
understand how a host molecule can interfere in the parasite’s
developmental process. Therefore, the aim of the present study is
to characterize T. cruzi molecules responsive to TGF-b through a
combined approach employing two-dimensional gel electropho-
resis (2DE) analysis and mass spectrometry (MS) protein identi-
fication. Here we show that incubation of T. cruzi epimastigotes
(Y strain) with TGF-b promotes a remodeling of the parasite
phosphorylation network and protein expression pattern influenc-
ing cellular processes such as metabolism, heat shock response,
cytoskeleton arrangement, oxidative stress regulation, translation,
signal transduction and proteolysis. We also observed that TGF-b
stimulated many biological events in different forms of T. cruzi,
such as epimastigote proliferation and differentiation of trypomas-
tigotes into amastigotes (amastigogenesis).
Materials and Methods
Cell Culture
Epimastigote forms of T. cruzi (Y strain) were grown in liver
infusion tryptose (LIT) medium supplemented with 10% fetal
bovine serum at 28uC.
Sample Preparation
Epimastigotes (5610
8) from 5-day-old cultures (exponential
growth phase) were centrifuged and washed two times with
phosphate buffered saline containing bovine serum albumin (PBS/
BSA 0.1%) and resuspended in the same buffer. Parasites were
incubated with TGF-b (5 ng/ml) for 1, 5, 30 or 60 minutes. The
samples were then centrifuged and washed twice with PBS,
resuspended in lysis buffer (PBS containing 1:100 protease and
phosphatase inhibitor cocktails from Sigma) and submitted to four
cycles of freeze–thawing. Samples were precipitated in 17%
tricholoracetic acid, centrifuged and the pellet washed in cold
acetone/triethanolamine 1%. The samples were solubilized in
isoelectric focusing buffer (2% CHAPS, 8 M urea) containing
phosphatase inhibitor cocktail (Sigma) and stored at 270uC.
Protein concentration was determined by the RCDC method
(BioRad), using bovine serum albumin as standard.
Two-Dimensional Electrophoresis (2DE)
Nonlinear IPG strips in the pH range 3–10 were rehydrated in a
buffer (8 M urea, 2 mM tributhylphosphine, 1% ampholytes, 2%
CHAPS) containing 100 mg (7 cm) or 500 mg (17 cm) of total
protein extracts. Isoelectric focusing was conducted on a Protein
IEF Cell (BioRad) according to the manufacturer’s instructions.
The strips were then re-equilibrated sequentially with 130 mM
DTT and 135 mM iodoacetamide in equilibration buffer (6 M
urea, 20% glycerol, 2% SDS) for 15 minutes each. Proteins within
the equilibrated strips were resolved on 12% SDS-PAGE gels.
Gel Staining
Gels were stained sequentially with phosphoprotein-specific
Pro-Q Diamond stain and the total protein stain Sypro Ruby (both
from Molecular Probes, Invitrogen) according to the manufactur-
er’s protocols. After that, gels were stained with colloidal
Coomassie Brilliant Blue G-250 (BioRad) as described elsewhere
[37].
Image Analysis
Protein spots were visualized by scanning the stained gels using
proper excitation and emission wavelengths in a Typhoon Trio
scanner (Applied Biosystems) and the obtained images were
analyzed with the PDQuest software version 8.0.1 (BioRad).
The spots were quantified on the basis of their relative volume:
the amount of a protein spot was expressed as the sum of
the intensities of all the pixels that made up the spot. As positive
and negativecontrolsfor thestaining ofphosphorylated proteinswe
used the PeppermintStick
TM phosphoprotein molecular weight
standard (Molecular Probes, Invitrogen), which is composed of a
mixture of phosphorylated and non-phosphorylated proteins. To
ensure that the values found were due to protein phosphorylation
and not to a higher load of proteins in acrylamide gels, we used a
ratiometric parameter by dividing the value obtained in Pro-Q
staining by the value obtained in Sypro Ruby staining for each spot
of interest. In this study, the analyses were based on the comparison
of protein expression and/or phosphorylation from T. cruzi
epimastigote samples treated or not with TGF-b at different times
(1,5,30or60minutes).Spotsdisplayingatleastatwo-folddifference
intheirpixelintensitywereassignedasdifferentiallyexpressedand/
or phosphorylated. We analyzed three to four gels for each
experimental condition and selected only spots with normalized
volumes that showed more than 2-fold increase or decrease after
TGF-b stimulation in at least one of the studied time points.
Protein Digestion and MS/MS Analysis
Selected protein spots were manually excised from 17 cm gels
and placed in 0.5 ml microtubes. Protein digestion and peptide
extraction were conducted as previously described [38].
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The Mascot software (www.matrixscience.com) was set up to
search the NCBInr database assuming the digestion enzyme as
trypsin and a peptide tolerance +/21.2 Da. The following
variable modifications were specified: Acetyl (protein N-term),
Carbamidomethyl (C), Deamidated (NQ), Gln RPyro-Glu (N-
termQ), Glu RPyro-Glu (N-term E), Oxidation (HW), Oxidation
(M), Phospho (ST) and Phospho (Y). Criteria for a positive protein
identification included Mascot scores, sequence coverage and
concordance between predicted molecular mass and isoelectric
point with values calculated from the 2DE gels.
Uni-Dimensional Electrophoresis (1DE) and Western
Blotting
Total protein extracts (20 mg) were mixed with protein loading
buffer (62,5 mM Tris-Cl pH 6,8/SDS 3%/Glicerol 10%/b-
mercaptoethanol 1:20) to a final volume of 20 ml. The mixture
was heated at 100uC for 5 minutes. The proteins were then
resolved on 12% SDS-PAGE and transferred to nitrocellulose
membranes (Hybond C, GE). Uniform sample loading and
transfer were verified using Memcode reversible protein stain
(Pierce). Non-specific binding sites were blocked by incubating the
membranes with 5% (w/v) nonfat milk/TBS/Tween-20 0.1% for
1 hour at room temperature. The membranes were probed with
specific primary antibodies (1:500 rabbit anti-elongation factor 1a,
1:20.000 mouse anti-beta-tubulin, both from Sigma-Aldrich, and
1:10.000 rabbit anti-cruzipain, gently given by Dr. Claudia Levy)
in 5% w/v nonfat milk/TBS/Tween-20 0,1% and detected with a
secondary antibody conjugated to peroxidase (HRP) from Pierce
for 1 hour at room temperature. Blots were developed using
Supersignal West Pico Chemiluminescent Substrate (Pierce),
recorded on autoradiography film and scanned with a GS-800
scanner (BioRad) at 600 dpi resolution.
Immunocytochemical Staining
Epimastigote forms of T. cruzi were washed with PBS and then
fixed on a 4% PFA solution for 20 min at 4uC. Fixed parasites
(5610
6) were incubated with 0.1% Triton X-100 in PBS, followed
Figure 1. Bidimensional phosphoproteome of T. cruzi Y strain epimastigotes. Representative images show the total protein patterns of
T. cruzi treated or not with TGF-b for 1, 5, 30 or 60 minutes. Protein extracts (100 mg) were separated on 7 cm pH 3–10NL IPG strips and 12% SDS-
PAGE gels. Phosphoproteins were stained with Pro-Q Diamond (shown in green) and total protein stained with Sypro Ruby (shown in red). Images
were artificially colored using PD Quest (BioRad) software tools. Phosphoprotein staining was confirmed with the visualization of the two positive
molecular weight control bands (Peppermint Stick – Molecular Probes). The molecular weight (MW) of marker proteins and the pH range of the IEF
gradient are indicated. N=3.
doi:10.1371/journal.pone.0038736.g001
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Then, cells were incubated with primary antibody raised against
recombinant cruzipain (1:1000) or with non-immune rabbit serum
diluted 1:100 in PBS, for 60 minutes at room temperature. After
washes with PBS, parasites were incubated for 60 minutes at room
temperature with secondary antibody (goat anti-rabbit Alexa 488
diluted 1:500; Invitrogen). To stain DNA, cells were incubated
with DAPI (1:5000; Sigma). The slides were then mounted in
BacLight Mounting Oil (Molecular Probes, Invitrogen) and
observed under an epifluorescence microscope (Nikon). Image
processing was performed using ImagePro.
In vitro Proliferation of Epimastigotes
Epimastigote forms of T. cruzi (Y strain) were incubated with
5 ng/ml of recombinant TGF-b1 (R&D). Epimastigote prolifer-
ation rates were evaluated after 24, 48, 72 and 96 hours of TGF-b
stimulation by quantifying the live parasites in a Neubauer
improved counting chamber.
In vitro Amastigogenesis
Infective trypomastigote forms of T. cruzi (Y strain) were
obtained from blood of infected mice at the peak of parasitemia. In
all assays, the living parasites were incubated in serum-free
medium. Amastigogenesis was promoted by acid induction as
previously described [39] and 5 ng/ml of recombinant TGF-b1
(R&D) were added to stimulate parasite differentiation. After
4 hours of acid induction with or without TGF-b stimuli,
differentiated amastigotes were quantified in a Neubauer im-
proved counting chamber and the percentage of differentiation
determined.
Results
Two-dimensional Proteomic Profile of T. cruzi
Epimastigotes in Response to TGF-b
To identify changes in protein phosphorylation and expression
patterns in response to TGF-b, we compared the intracellular
proteome of T. cruzi epimastigotes treated or not with this
cytokine. In order to assess early and long-term changes in protein
phosphorylation and expression patterns, cells were treated with
TGF-b for 1, 5, 30 or 60 minutes and compared with non-treated
cells (Figure 1).
Approximately 200 protein spots were resolved in gels stained
with Sypro Ruby. A total of 75 protein spots (37.5%) were found
to be more than 2-fold up- or down-regulated after TGF-b
treatment. From these, 42 were identified by mass spectrometry
(Table 1) and are indicated in the proteomic map shown in
Figure 2.
Figure 2. Proteomic map of T. cruzi epimastigotes. The image shows the total protein pattern of epimastigotes treated with TGF-b for 1 minute
and separated by 2D-PAGE (17 cm IPG strips in the pH range 3-10NL and 12% SDS-PAGE, CBB-G250 staining). The colored circles indicate protein
spots identified by mass spectrometry that differ significantly only in their phosphorylation (green), or in their expression (red) or in both (brown)
levels in one or more studied time points. The molecular weight (MW) of marker proteins and the pH range of the IEF gradient are indicated. N=3.
doi:10.1371/journal.pone.0038736.g002
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In our analysis, 20 protein spots showed consistent phos-
phorylation changes during all studied times (Table 2). Phos-
phorylation of 50% of the identified proteins was rapidly
increased after 1 minute treatment with TGF-b. Proteins with
highest phosphorylation changes in response to TGF-b, at each
time point, were identified as: mitochondrial precursor Hsp70
(spot 5) in 1 minute; beta-tubulin (spot 9) in 5 minutes; IgE-
dependent histamine-releasing factor (IgE-HRF, spot 34) in 30
minutes and glycosomal malate dehydrogenase (GMD, spot 41)
in 60 minutes. Proteins like prostaglandin F2-alpha synthase and
enolase were identified in two phosphoprotein spots of similar
molecular mass, suggesting that these proteins have at least two
different sites of phosphorylation. Phosphoprotein spots that
showed the highest phosphorylation index at each studied time
point are shown in selected zoom areas of images from gels
stained with Pro-Q Diamond containing the non-treated and
TGF-b treated parasites (Figure 3A and B).
On the other hand, 8 protein spots had their phosphorylation
reduced in response to TGF-b addition. The most dephosphor-
ylated proteins observed in each time point of the study were
identified as: glycosomal malate dehydrogenase (GMD, spot 41) in
1 minute; prostaglandin F2- alpha synthase (Pf2aS, spot 21) in 5
minutes; hypothetical protein (spot 24) in 30 minutes and
mitochondrial precursor Hsp70 (spot 5) in 60 minutes of TGF-b
treatment (Figure 3C and D and Table 2).
Protein Expression Changes in Response to TGF-b
From all 41 identified protein spots showing expression
changes in response to TGF-b treatment (Table 3), 5 spots were
surprisingly up-regulated already in the first minute of
incubation, with cyclophilin A (spot 42) and DnaK (spot 1),
two heat shock proteins, showing the highest induction change.
At 5 minutes of treatment, 19 protein spots had suffered an
increase in expression levels, including the main protein
regulated by TGF-b, cruzipain (spot 15), with a dramatic mean
38 fold increase in expression in parasites treated with TGF-b
compared to those untreated with this cytokine. In the longer
incubation times, 6 protein spots were up-regulated by TGF-b
and the main effect was in a hypothetical protein (spot 24) in 30
minutes and tryparedoxin peroxidase (TRYP, spot 38) in 60
minutes of TGF-b stimulation (Figure 4A and B).
Our data also demonstrated that incubation with TGF-b led
to a down–regulation in expression of many proteins in the
studied time frame. From the 23 protein spots down-regulated
by TGF-b, 30% were already down-regulated in the first
minute, with Prostaglandin F2- alpha synthase (Pf2aS, spot 12)
being the most repressed. Methylthioadenosine phosphorylase
(MTAP, spot 32) was the most down-regulated protein after 5
minutes of TGF-b addition. In the longer incubation times, 20
protein spots had their expression level decreased, with enolase
(spot 17) and the chaperonin Hsp70 (spot 3) showing the
greatest decrease in expression after 30 and 60 minutes of TGF-
b incubation, respectively (Figure 4C and D and Table 3).
Separation of these proteins into functional groups (Figure 5)
shows that most of them are involved in metabolic processes
(39%), while others are related to heat shock response (24,4%),
translation (12,2%), proteolysis (7,3%), cytoskeleton composition
(4,9%), signal transduction (4,9%), oxidative stress regulation
(2,4%) and hypothetical proteins (7,3%).
Table 2. Proteins with changes in phosphorylation pattern in response to TGF-b.
Fold Changes
FUNCTIONAL GROUPS SPOT NUMBER PROTEIN NAME 1 min 5 min 30 min 60 min
HEAT SHOCK PROTEINS 5 mitochondrial precursor HSP70 8,39 0,72 1,76 0,43
6 mitochondrial precursor HSP70 3,22 0,00* 4,23 2,43
3 HSP70 1,95 1,09 2,05 1,48
7 mitochondrial precursor HSP60 3,65 0,00* 1,11 1,92
14 Hsc70 1,90 1,33 1,35 0,55
CYTOSKELETON PROTEINS 9 beta-tubulin 1,06 2,88 2,13 0,49
27 beta-tubulin 3,13 1,00 1,33 0,53
METABOLISM PROTEINS 11 Prostaglandin F2 alpha synthase 6,36 0,00* 0,00* 3,91
12 Prostaglandin F2 alpha synthase 5,10 4,48 0,82 3,72
21 Prostaglandin F2 alpha synthase 0,45 0,24 3,34 0,37
16 Enolase 3,26 0,08 0,31 1,61
17 Enolase 0,00* 0,00* 2,06 2,30
40 GAPDH 3,42 0,43 1,13 2,52
41 Glycosomal malate dehydrogenase 0,35 2,12 1,66 24,07
HYPOTHETICAL PROTEINS 24 Hypothetical protein 1,79 0,35 0,16 0,00*
25 Hypothetical protein 0,63 0,58 2,05 4,28
TRANSLATION-ASSOCIATED PROTEINS 30 Nascent polypeptide associated complex subunit 2,31 0,47 3,99 0,53
36 Eukaryotic initiation factor 5a 0,62 0,93 0,70 2,19
SIGNAL TRANSDUCTION PROTEINS 34 IgE-dependent histamine-releasing factor 1,90 0,69 4,58 18,58
PROTEASES/PEPTIDASES 10 peptidase M20/M25/M40 4,39 0,00* 2,48 2,00
Fold changes presents the ratio compared with values in the absence of TGF-b stimulation.
*Values equal to zero correspond to spots that could not be detected on gels.
doi:10.1371/journal.pone.0038736.t002
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separated according to their functional classification (Figure 5, in
green). These proteins are involved in metabolism (40%), heat
shock response (25%), cytoskeleton (10%), translation (10%), signal
transduction (5%), proteolysis (5%) and hypothetical proteins
(10%).
Western blot (WB) assays were performed for some proteins
(elongation factor 1–alpha, beta-tubulin and cruzipain) shown to
be regulated by TGF-b in the proteomic analysis, corroborating
the 2-DE results, as observed in Figure 6. Both approaches
presented the same kinetic patterns, but the absolute fold increase
or decrease values were substantially different, possibly reflecting
the known differences in sensitivity between these two methods.
Thedramaticincreaseincruzipainexpressionwasalsoconfirmed
by an immunofluorescence assay (Figure 7), that allowed us to
visualize its sub- cellular localization on fixed epimastigotes. The
resultsdemonstratedatypicallabelingofroundedstructureslocalized
attheposteriorregion,indicatingapossiblecompartmentalizationin
reservosomes,especiallyoncontrolparasites(Figure7AandC).After
TGF-b addition, the immunofluorescence analysis of cruzipain
stainingclearlyincreasedanditwaspossibletoobserveamoreintense
labelingintheflagellarpocketregion(Figure7BandD,whitearrow).
Figure 3. Proteins that presented the major phosphorylation changes in response to TGF-b. Magnified regions showing protein spots
that presented the greatest up- (A) or down-(C) phosphoregulation and their respective bar graphics (B and D) with the mean fold change values.
doi:10.1371/journal.pone.0038736.g003
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38736The intensity of cruzipain staining was quantified using the NIH
ImageJ software in the microscopic images of labeled parasites
(Figure 7C, D and E).
To test if the changes observed in epimastigotes 2DE profiles
after TGF-b addition could be involved in biological events of the
parasite’s life cycle, epimastigotes were incubated with or without
Table 3. Proteins with changes in expression pattern in response to TGF-b.
Fold Changes
FUNCTIONAL GROUPS SPOT NUMBER PROTEIN NAME 1 min 5 min 30 min 60 min
HEAT SHOCK PROTEINS 5 mitochondrial precursor Hsp70 1,02 1,01 0,64 0,65
6 mitochondrial precursor Hsp70 1,50 1,58 4,23 2,43
4 Hsp70 1,04 6,15 0,54 0,41
3 Hsp70 0,00* 1,55 0,41 0,05
7 mitochondrial precursor Hsp60 1,62 0,85 0,32 0,68
8 mitochondrial precursor Hsp60 1,09 1,28 0,67 0,30
1 DnaK 3,90 3,13 0,00* 0,00*
14 Hsc70 1,08 1,55 1,14 1,22
37 GrpE 0,61 0,93 2,83 2,24
42 Cyclophilin A 5,45 1,11 4,13 0,63
CYTOSKELETON PROTEINS 9 beta-tubulin 2,23 3,39 0,38 0,31
27 beta-tubulin 1,10 1,27 0,62 0,49
METABOLISM PROTEINS 11 Prostaglandin F2 alpha synthase 1,18 1,70 1,16 0,67
12 Prostaglandin F2 alpha synthase 0,26 0,84 0,95 0,73
20 Prostaglandin F2 alpha synthase 1,51 1,00 0,22 0,53
21 Prostaglandin F2 alpha synthase 1,37 4,14 0,27 1,67
22 Prostaglandin F2 alpha synthase 2,58 2,95 0,26 1,18
23 Prostaglandin F2 alpha synthase 0,65 3,52 6,20 0,50
31 Aldo-ketoreductase 0,81 1,29 0,38 0,79
16 Enolase 0,58 13,06 1,48 1,32
17 Enolase 0,80 0,60 0,18 1,92
18 Alanine aminotransferase 1,32 8,05 1,27 5,64
40 GAPDH 0,50 2,34 0,95 0,55
41 Glycosomal malate dehydrogenase 1,06 3,37 1,37 0,24
26 Protein disulfide isomerase 1,09 8,07 1,05 1,32
29 Aromatic L-alpha-hydroxyacid dehydrogenase 0,99 2,70 0,42 0,97
19 Tyrosine aminotransferase 1,12 1,38 1,69 1,19
HYPOTHETICAL PROTEINS 24 Hypothetical protein 1,17 0,73 16,71 1,29
25 Hypothetical protein 0,56 7,84 1,58 0,33
13 Hypothetical protein 2,20 8,03 0,32 7,24
TRANSLATION-ASSOCIATED
PROTEINS
30 Nascent polypeptide associated complex
subunit
1,07 1,57 1,38 1,04
36 Eukaryotic initiation factor 5a 1,46 0,60 0,95 1,03
28 Elongation factor 1 alpha 0,95 24,62 0,54 1,24
39 Elongation factor 1 alpha 1,09 4,20 1,55 0,29
35 Proteasome alpha 1 subunit 0,81 1,42 0,86 2,80
SIGNAL TRANSDUCTION PROTEINS 32 Methylthioadenosine phosphorylase 0,55 0,36 0,72 0,73
34 IgE-dependent histamine-releasing factor 0,80 0,70 1,82 0,26
PROTEASES/PEPTIDASES 15 Cruzipain 0,65 38,07 0,42 1,49
10 peptidase M20/M25/M40 1,62 10,03 1,14 0,45
33 hslvu complex proteolytic subunit-like 0,94 4,00 0,79 0,59
OXIDATIVE STRESS REGULATING
PROTEINS
38 Tryparedoxin peroxidase 0,55 1,38 0,71 11,82
Fold changes presents the ratio compared with values in the absence of TGF-b stimulation.
*Values equal to zero correspond to spots that could not be detected on gels.
doi:10.1371/journal.pone.0038736.t003
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38736TGF-b (5 ng/ml TGF-b, added daily) for 96 hours. Our results
showed that TGF-b addition promoted an increase in epimasti-
gote proliferation in all studied time points. After 24 hours, we
observed an 88% increase in growth compared to epimastigotes
cultivated in LIT medium only (Figure 8A). After verifying the
biological effect of TGF-b on epimastigotes, we investigated if
TGF-b could also influence the amastigote (normally intracellular,
replicative) forms of T. cruzi. For that, we performed an
amastigogenesis assay, in which trypomastigotes were submitted
to acidic conditions with or without 5 ng/ml TGF-b for 4 hours.
We observed that treatment resulted in a higher rate of
differentiation of trypomastigotes into amastigotes (36%) com-
pared to trypomastigotes submitted to acidic conditions only
(Figure 8B). These data indicate that TGF-b acts as a powerful
regulator in different forms of T. cruzi, present both in vertebrate
and invertebrate hosts.
Discussion
In recent years, several groups have used a proteomic approach
to study T. cruzi biology, trying to identify new factors for
diagnostics, virulence, infectivity and mainly, drug targets
Figure 4. Proteins that presented the major expression changes in response to TGF-b. Magnified regions showing protein spots that
presented the greatest up- (A) or down-(C) regulation in expression and their respective bar graphics (B and D) with the mean fold change values.
doi:10.1371/journal.pone.0038736.g004
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38736[29,31,32,34,40,41]. Signal transduction pathways are highly
dynamic protein networks that integrate information from various
stimuli. We and others demonstrated previously the involvement
of TGF-b in T. cruzi life cycle [6,7,8,12], but a study of parasite
proteins responsive to TGF-b stimulus was still lacking. Here, we
have profiled for the first time a global and kinetic view of T. cruzi
epimastigote proteins responsive to TGF-b using a (phospho)
proteomic approach.
Reversible protein phosphorylation is a key mechanism for the
regulation of major biological processes including metabolism,
proliferation, molecule transport and differentiation. Approxi-
mately 2% of the T. cruzi genome encodes protein kinases [42],
suggesting a major regulatory role for protein phosphorylation in
parasite development and adaptation.
In this study, we used the Pro-Q Diamond technology, which
provides a method for selectively staining phosphoproteins in
polyacrylamide gels. Proteomic studies addressing the response
triggered by TGF-b in different cellular models have been
reported [25,43,44], showing that TGF-b stimuli result in negative
or positive regulation of proteins involved in diverse functions,
such as cytoskeleton arrangement, RNA processing, proteolysis,
metabolism and extracellular matrix synthesis. Some of the
proteins we found to be regulated by TGF-b have already been
described to be directly associated with this molecule, participating
in many physiological processes in the life cycle of protozoan
parasites.
We observed that the mitochondrial precursor Hsp70 had an 8-
fold increase in phosphorylation after one minute of incubation
with TGF-b, being one of the proteins to present a fast and strong
phosphorylation change in response to TGF-b. Heat shock
proteins (Hsps) act as molecular chaperones, binding to a subset
of newly synthesized polypeptides to assist their folding to a well-
defined three-dimensional conformation [45]. Comparative pro-
teomics of developmental stages of Leishmania donovani and T. cruzi
show differences in expression of Hsp60, Hsp70, mitochondrial
Hsp70 and Hsp90 [28,46]. A recent study [47] reported that
Hsp70 interacts with Smad2 and decreases TGF-b signal
transduction.
Tryparedoxin peroxidase (TRYP) was also shown to be
positively regulated by TGF-b. This protein is described as
participating in distinct functions, including general cell detoxifi-
cation and specific signaling during proliferation or differentiation
processes [48]. Our findings lead to the speculation that TGF-b
participates in the differentiation process triggered by TRYP
corroborating to previous study in which it was observed that the
inhibition of TGF-b pathway impaired T. cruzi differentiation into
trypomastigotes at the end of intracellular cycle [8].
Most of TGF-b-responsive proteins pointed out in our study are
associated with metabolic functions. Our data show that
phosphorylation of glycosomal malate dehydrogenase (GMD)
increases on average 24-fold, 60 minutes after TGF-b addition.
This protein participates in sustaining energy supply by acting in
parasite’s aromatic amino acid catabolism. Trypanosomatids
depend on these nutrients for a number of vital cell functions
such as protein synthesis, osmoregulation, energy production and
polyamine biosynthesis, since carbohydrates are rarely available in
the gut of haematophagous insects [49]. Some proteins, like
enolase, presented a reduction in expression levels only in the
longest period of induction with TGF-b. Enolase (2-phospho-D-
glycerate hydrolase) participates in both glycolysis and gluconeo-
genesis [50]. It was also described as a prokaryotic RNA
degradosome component [51,52], which might have implications
on RNA stabilization and/or degradation, favoring the post-
transcriptional control of T. cruzi gene expression.
TGF-b also appears to influence the parasite’s cytoskeleton
arrangement, through the modulation of b-tubulins, the proteins
that form microtubules, and play an important role in the
morphological changes associated with the life cycle of trypano-
somes [53,54,55]. Our data show that this protein is positively
regulated by TGF-b, consistent with the role of TGF-b on
proliferation and differentiation of the parasite. Tubulin has
previously been shown to be up-regulated in hepatic stellate cells
Figure 5. Distribution of the identified proteins into functional groups. Bar graphs presenting the functional groups of proteins that had
their expression (red) or phosphorylation (green) regulated by TGF-b.
doi:10.1371/journal.pone.0038736.g005
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PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e38736Figure 6. Kinetic view of protein expression in response to TGF-b. Expression pattern of elongation factor 1-a (A), b-tubulin (B) and cruzipain
(C) from T. cruzi epimastigotes incubated with TGF-b at different periods of time. The graphics represent the values found for the kinetic of these
proteins obtained through a 2DE approach and Western blot analysis.
doi:10.1371/journal.pone.0038736.g006
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PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38736Figure 7. TGF-b induces cruzipain expression in T. cruzi epimastigotes. Parasites treated (B) or not with TGF-b (A) for 5 minutes were
immunostained for cruzipain and corresponding histograms were obtained using the ImageJ software (C and D). The quantification of the parasite
areas labeled for cruzipain were determinate by the mean of RGB color and demonstrated as a bar graphic (E).
doi:10.1371/journal.pone.0038736.g007
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e38736treated with TGF-b [56]. Moreover, the association of endogenous
Smads with microtubules has been shown to be an important
feature of TGF-b signaling [57].
Interestingly, a tubulin binding protein, named IgE-dependent
histamine-releasing factor, had its phosphorylation increased 30
minutes after TGF-b stimulus. It is also known as translationally-
controlled-tumor-protein (TCTP) and various cellular functions
and molecular interactions have been ascribed to this protein,
many related to its growth-promoting and anti-apoptotic proper-
ties. Since it has been characterized as an anti-apoptotic protein
[58,59] and the blockage of the TGF-b intracellular pathway
induces higher levels of intracellular amastigote apoptosis [8], this
protein could play a role in T. cruzi survival, through the
abrogation of apoptosis induction, but further studies should be
done to confirm this hypothesis.
In our study, the protein with the highest positive regulation was
cruzipain, the major T. cruzi papain-like cysteine proteinase. This
molecule is expressed in all life-cycle stages of the parasite, being
more abundant in replicating forms and especially in the insect
epimastigote stage. Cruzipain participates in the nutrition of the
parasite at the expense of the host, being the major proteinase of
the large acidic prelysosomal compartment called reservosomes.
Cruzipain also plays a role in the invasion of host cells by T. cruzi
trypomastigotes and participates in the escape mechanisms used
by the parasite to evade the immune system of the host [60,61].
Cruzipain has been shown to enhance IL-10 and TGF-b
production, favoring parasite survival in macrophages [62]. The
involvement of this protein in the capacity of T. cruzi to activate
TGF-b has already been proposed by us [8] and is under further
investigation in our laboratory. Additionally, our results showed
that TGF-b was also capable to stimulate in vitro amastigogenesis,
extending previous data which demonstrate that epimastigotes
overexpressing cruzipain have a higher rate of differentiation into
metacyclic forms [63].
The absence of classical signaling molecules found in our study
may be explained by the low abundance of these proteins, or due
to stoichiometry and kinetic factors of their phosphorylation, being
considered as a limitation of the chosen technique. However,
recently, combination of phosphopeptide enrichment approaches
with more sensitive mass spectrometry-based methodologies
[64,65] have been applied to the study of general protein
phosphorylation in T. cruzi at the epimastigote stage, enabling
the identification, quantification and description of site-specific
phosphorylation in this microorganism, but failing to identify any
of the classical TGF-b signaling molecules. Another hypothesis
suggests that TGF-b triggers alternative signaling routes in T. cruzi,
independent of the pathways already described in more complex
eukaryotes.
The idea of a signaling pathway triggered by TGF-b suggests
the presence of TGF-b receptor(s) on the T. cruzi cell surface in
order to initiate an intracellular cascade. However, no orthologs
and/or analogs of the canonical serine-threonine kinase TGF-b
receptors (TRI and TRII) have been found after in silico analysis of
the T. cruzi genome [12]. A molecular analysis of the probable T.
cruzi TGF-b receptor protein is under investigation in our
laboratory. It should be remarked that other mammalian growth
factors (namely epidermal growth factor and TGF-a) have been
shown to bind to an EGF-like receptor and induce signal
transduction events and cellular proliferation in T. cruzi axenic
amastigotes [66,67].
Protein phosphorylation is strongly associated with the processes
of cell signaling and development in eukaryotes. Post-transcrip-
tional modifications appear to be even more important for the
regulation of gene expression in the Kinetoplastids, since they lack
several transcriptional control mechanisms [36,68,69]. Besides the
quantity of information generated by a phosphoproteomic
approach, it is extremely challenging to connect the kinases to
their molecular targets. This challenge reflects both the complexity
and variety of functions played by these proteins and also the fact
that kinases usually exert their biological effects through the
simultaneous phosphorylation of different sites of a protein or in
multiple protein complexes. We have identified a series of proteins
responsive to TGF-b, but the interactions established among them
and their role in the signaling triggered by TGF-b remains to be
fully understood.
Although we could not determine a linked network between the
modulated proteins, the stimulation of epimastigote growth by
TGF-b may be partially attributed to positive regulation of
proteins like TRYP, tubulin, and TCTP, which have already been
described to participate in the process of proliferation and
prevention of apoptosis. These functions are compatible with
epimastigote biology in the bug’s crop following a blood meal, thus
suggesting that TGF-b may play an important role in these
Figure 8. Biological effects exerted by TGF-b over different
forms of T. cruzi. A. In vitro proliferation of epimastigotes.
Epimastigotes were grown in the absence or presence of TGF-b
(5 ng/ml, daily added) in LIT medium. The graph represents the mean
number of epimastigotes present in cultures treated or not with TGF-b
after 24, 48, 72 and 96 hours. N=4. **p,0.01, ***p,0.001. B.
Amastigogenesis in vitro. Differentiation of trypomastigotes was
performed by acid induction followed or not by treatment with 5 ng/
ml of recombinant TGF-b 1. The graph represents the percentage of
differentiation into amastigote forms after 4 hours of acid induction
with or without TGF-b stimuli. N=4. **p,0.01.
doi:10.1371/journal.pone.0038736.g008
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appears to have an essential role in the development of insect
immunity. It has been reported [70] that during blood meal, the
Anopheles mosquito vector ingests a variety of mammalian
signaling factors - including TGF-b - that can communicate with
immunological cells of the invertebrate host. This study demon-
strates that cytokine transmission is not only critical for Plasmo-
dium development in the vertebrate host, but can also influence
parasite development in the mosquito, thus indicating that through
a conserved immunological cross talk, mammalian and insect
immune systems interact with each other to influence the
Plasmodium life cycle.
In view of the important role of TGF-b during the parasite life
cycle and in development of infection, the present study
contributes for the elucidation of T. cruzi epimastigote proteins
that may be involved in many biological processes in which TGF-
b participates, such as invasion, proliferation, differentiation and
survival, thereby reinforcing the importance of this molecule in the
different forms and stages of the T. cruzi life cycle.
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